药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Methoxyamphetamine
Prednisolone phosphate
The serum concentration of Prednisolone phosphate can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Remdesivir
The serum concentration of Remdesivir can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Larotrectinib
The serum concentration of Larotrectinib can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Tenofovir
The serum concentration of Tenofovir can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Enfortumab vedotin
The serum concentration of Enfortumab vedotin can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Grapiprant
The serum concentration of Grapiprant can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Lefamulin
The serum concentration of Lefamulin can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Omadacycline
The serum concentration of Omadacycline can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Lemborexant
The serum concentration of Lemborexant can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Fostemsavir.
4-Methoxyamphetamine
Revefenacin
Fostemsavir may decrease the excretion rate of Revefenacin which could result in a higher serum level.
4-Methoxyamphetamine
Bempedoic acid
The excretion of Bempedoic acid can be decreased when combined with Fostemsavir.
4-Methoxyamphetamine
Metreleptin
The metabolism of Fostemsavir can be increased when combined with Metreleptin.
4-Methoxyamphetamine
Levosalbutamol
The excretion of Levosalbutamol can be decreased when combined with Fostemsavir.
4-Methoxyamphetamine
Atrasentan
The excretion of Atrasentan can be decreased when combined with Fostemsavir.
4-Methoxyamphetamine
Relugolix
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Relugolix.
4-Methoxyamphetamine
Inotersen
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Inotersen.